MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on March 31, 2009; DOI: 10.1124/mol.108.053363


0026-895X/09/7506-1347-1355$20.00
Mol Pharmacol 75:1347-1355, 2009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.108.053363v1
75/6/1347    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by McCavera, S.
Right arrow Articles by Wolstenholme, A. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCavera, S.
Right arrow Articles by Wolstenholme, A. J.

An Ivermectin-Sensitive Glutamate-Gated Chloride Channel from the Parasitic Nematode Haemonchus contortus

Samantha McCavera, Adrian T. Rogers, Darran M. Yates1, Debra J. Woods, and Adrian J. Wolstenholme

Department of Biology and Biochemistry, University of Bath, Claverton Down, Bath, United Kingdom (S.M., A.T.R., D.M.Y., A.J.W.); and Pfizer Animal Health, Kalamazoo, Michigan (D.J.W.)

Nematode glutamate-gated chloride channels are targets of the macrocyclic lactones, the most important group of anthelmintics available. In Xenopus laevis oocytes, channels formed by the GluCl{alpha}3B subunit from the parasite Haemonchus contortus were more sensitive to L-glutamate (EC50 = 27.6 ± 2.7 µM) than those formed by the homologous subunit from Caenorhabditis elegans (EC50 = 2.2 ± 0.12 mM). Ibotenate was a partial agonist (EC50 = 87.7 ± 3.5 µM). The H. contortus channels responded to low concentrations of ivermectin (estimated EC50 =~0.1 ± 1.0 nM), opening slowly and irreversibly in a highly cooperative manner: the rate of channel opening was concentration-dependent. Responses to glutamate and ivermectin were inhibited by picrotoxinin and fipronil. Mutating an N-terminal domain amino acid, leucine 256, to phenylalanine increased the EC50 for L-glutamate to 92.2 ± 3.5 µM, and reduced the Hill number from 1.89 ± 0.35 to 1.09 ± 0.16. It increased the Kd for radiolabeled ivermectin binding from 0.35 ± 0.1 to 2.26 ± 0.78 nM. Two other mutations (E114G and V235A) had no effect on L-glutamate activation or ivermectin binding: one (T300S) produced no detectable channel activity, but ivermectin binding was similar to wild-type. The substitution of any aromatic amino acid for Leu256 had similar effects in the radioligand binding assay. Molecular modeling studies suggested that the GluCl subunits have a fold similar to that of other Cys-loop ligand-gated ion channels and that amino acid 256 was unlikely to play a direct role in ligand binding but may be involved in mediating the allosteric properties of the receptor.


Received for publication November 7, 2008.

Accepted for publication March 24, 2009.

Address correspondence to: A. J. Wolstenholme, Dept of Biology and Biochemistry, University of Bath, Bath BA2 7AY, UK. E-mail: a.j.wolstenholme{at}bath.ac.uk







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2009 by the American Society for Pharmacology and Experimental Therapeutics